CoImmune Funding: $45M Raised, Series A (2020)

CoImmune is based in Durham. It has raised $45M in total funding. Latest round: Series A. Backed by Lucio Rovati, DSC Investment.

CoImmune funding overview

CoImmune is based in Durham. CoImmune has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2020. The round record for CoImmune runs through 2020; nothing later has been disclosed. Investors on record include Lucio Rovati, DSC Investment. 2 distinct backers are named across the disclosed rounds.

CoImmune at a glance

Total raised
$45M
Latest round
Series A
Latest round date
November 2020
Headquarters
Durham
Notable investors
Lucio Rovati, DSC Investment

Frequently asked about CoImmune funding

How much has CoImmune raised?
CoImmune has raised $45M in total disclosed funding across the rounds on record.
Who has invested in CoImmune?
Lucio Rovati, DSC Investment are named among the investors backing CoImmune.
What was the latest CoImmune funding round?
The most recent disclosed round is a Series A, announced in November 2020.
Where is CoImmune based?
CoImmune is based in Durham.
When did CoImmune last raise?
The last disclosed CoImmune round closed in November 2020 at Series A.

Totals shown for CoImmune aggregate every disclosed round on file. To see how that compares, browse the companies in Durham and the investors behind them below.

Companies related to CoImmune (18)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026